Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma

By Yáñez Yania   Grau Elena   Oltra Silvestre   Cañete Adela   Martínez Francisco   Orellana Carmen   Noguera Rosa   Palanca Sarai   Castel Victoria  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1263-1272

Springer Publishing Company

Access to resources Recommend Favorite

Diagnosis of Minimal Residual Disease in Bone Marrow and Blood in Cancer Patients: Methods and Clinical Implications

By Kvalheim G.  

Acta Oncologica, Vol. 37, Iss. 5, 1998-10 ,pp. : 455-462

Informa Healthcare

Access to resources Recommend Favorite

Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells

By                                            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1629-1636

Spandidos Publications

Access to resources Recommend Favorite

Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

By Kasimir-Bauer S.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 123-132

Springer Publishing Company

Access to resources Recommend Favorite

Over-Expression of Cancerous Inhibitor of PP2A (CIP2A) in Bone Marrow Cells from Patients with a Group of High-Risk Myelodysplastic Syndromes

By Li Na   Abe Shinya   Kurata Morito   Abe-Suzuki Shiho   Onishi Iichiroh   Kirimura Susumu   Murayama Toshihiko   Hidaka Michihiro   Kawano Fumio   Kitagawa Masanobu  

Pathology & Oncology Research, Vol. 20, Iss. 2, 2014-04 ,pp. : 399-407

Springer Publishing Company

Access to resources Recommend Favorite